0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
Powered by :
Zydus launches Zyrifa, a Denosumab biosimilar for patients with bone metastases, improving access to critical cancer care and supporting better mobility and treatment outcomes.
Share this article
If you liked this article share it with your friends.they will thank you later